TUCSON, AZ – CDEX Inc. (OTCBB: CEXI) (www.cdex-inc.com), a leading developer of chemical detection products, using patented technologies, for use in healthcare and security markets, announced today the company has signed a new Master Distribution Agreement (MDA) with Decatur Electronics, Inc. to market and distribute its Pocket ID2 drug detection scanner. The new MDA provides non-exclusive marketing and distribution rights to Decatur in the U.S. and worldwide markets for the Pocket ID2.

Decatur has been a distribution partner with CDEX for over two years. Decatur will market the Pocket ID2 to law enforcement agencies at federal, state and local levels, correction facilities, the Department of Defense and Homeland Security agencies in the U.S. and similar agencies internationally.

“We are very excited to sign a new distribution agreement with Decatur, they have been a great partner to date and we look forward to continued success. Our new agreement provides Decatur with distribution rights worldwide for our new Pocket ID2 which is the predecessor of the ID2 Meth scanner. The Decatur sales team has tested the Pocket ID2, and the initial reaction and feedback is very favorable,” stated Jeff Brumfield, chief executive officer and chairman of CDEX. “The revised MDA has built in annual sales minimums for the first three years and every year thereafter, which reflects the confidence in our products widespread appeal. Decatur will feature the Pocket ID2 at industry tradeshows as well as their marketing collateral and promotional materials, which should bolster its recognition and approval in the market.”

The Pocket ID2 allows law enforcement officers and other agencies to carry and conceal the device easily providing immediate access for testing. The Pocket ID2 was developed with the Company’s patented technologies that detect and verify the presence of meth at the visible and prosecutable range. Test results are instantaneous and non-destructive and can be conducted without touching or disturbing the surfaces scanned, thus minimizing officer exposure and preserving the integrity of the sample substance. The innovative technology is designed for use in law enforcement, correctional facilities and other applications where definitive and immediate results are necessary. The company is currently developing the Pocket ID2 for testing of Cocaine and other substances, which will further enhance and advance its capabilities.

About Decatur Electronics

Decatur Electronics, a Soncell NA Company, has manufactured products for public safety departments for over 50 years. As the United States’ oldest manufacturer of police radar, Decatur has a long history of providing police radar, police in car video systems and speed trailers to men and women who protect our communities as well as servicing those products after the sale. To learn more about Decatur Electronics please visit www.decaturelectronics.com

About CDEX

CDEX develops, manufactures and globally distributes products to the healthcare and security markets. The ValiMed product line provides life-saving validation of high-risk medications and returned narcotics. The ID2™ product line detects trace amounts of illegal drugs, such as methamphetamine. CDEX expects to advance its patented technologies to serve additional markets in the future where its proprietary products can be launched. To learn more about CDEX please visit www.cdex-inc.com.

Safe Harbor Statement

Non-historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as “expects,” “plans,” “may,” “believes,” “should,” “intends,” and similar words. These statements pose risks that cannot be accurately predicted. Consequently, results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the protection of intellectual property and proprietary information, and other risks detailed periodically in filings with the SEC. There is no obligation to update any forward-looking statements.